Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4Thoracic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 1Advanced Breast Cancer 1

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lead × Breast × 1 year × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

NCT01517945 2026-04-24

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Memorial Sloan Kettering Cancer Center

Active not recruiting
252 enrolled
Breast

Breast Neoplasms

NCT07014618 2025-12-17

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

University of Oklahoma

Recruiting
420 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06640881 2025-10-01

REPEAT

Amsterdam UMC, location VUmc

Phase 2 Recruiting
25 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡